Current clinical efficacy of chloroquine for the treatment of Plasmodium falciparum infections in urban Dar es Salaam, United Republic of Tanzania

Bulletin of the World Health Organization

Volumn 77, Issue 9, 1999, Pages 740-744

  Premji, Z ^a   Makwaya, C ^a   Minjas, J N ^a  

^a MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; PYRIMETHAMINE; SULFADOXINE;

DISEASE CONTROL; DRUG PRESCRIBING; INFECTIOUS DISEASE; URBAN SOCIETY;

ADULT; ARTICLE; DRUG EFFECT; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; PARASITEMIA; PLASMODIUM FALCIPARUM; TANZANIA; URBAN AREA;

AGE FACTORS; ANTIMALARIALS; CHILD, PRESCHOOL; CHLOROQUINE; DRUG COMBINATIONS; DRUG EVALUATION; HUMANS; INFANT; MALARIA, FALCIPARUM; PYRIMETHAMINE; SULFADOXINE; TANZANIA; URBAN POPULATION;

TANZANIA;

EID: 0032832805     PISSN: 00429686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Kihamia CM et al. Chloroquine resistant falciparum malaria in semi-immune African Tanzanians. Lancet, 1982, 2: 43.
2. Fowler VG et al. Efficacy of chloroquine on Plasmodium falciparum transmitted at Amani, Eastern Usambara mountains, North-east Tanzania: an area where malaria has recently become endemic. Journal of tropical medicine and hygiene, 1993, 96: 337-345.
3. Bloland PB et al. Beyond chloroquine: implications of drug resistance for evaluating malaria therapy efficacy and treatment policy in Africa. Journal of infectious diseases, 1993, 167: 932-937.
4. Chemotherapy of malaria and resistance to antimalrials, Report of a WHO Scientific Group. Geneva, World Health Organization, 1973 (WHO Technical Report Series, No. 529).
5. Assessment of therapeutic efficacy of antimalarial drugs for uncomplicated falciparum malaria in areas with intense transmission. Geneva, World Health Organization, 1996 (unpublished document WHO/MAL/96.1077, available upon request from Communicable Disease Prevention and Control, World Health Organization, 1211 Geneva 27, Switzerland).
6. Irare SM et al. The evolution and current status of antimalarial drug resistance in United Republic of Tanzania. In: Kager PA, Polderman AM, eds. Abstracts of International Congress for Tropical Medicine and Malaria, 18-23 September 1988, Amsterdam. Excerpta Medica, Amsterdam, Excerpta Medica International Congress Series 1988, 810.
7. Mshinda H et al. A comparative study of the efficacies of chloroquine and a pyrimethamine-dapsone combination in clearing Plasmodium falciparum parasitaemia in school children in United Republic of Tanzania. Tropical medicine and international health, 1995, 6: 797-801
8. Schapira A et al. Malaria: living with drug resistance. Parasitology today, 1993, 9: 186-174.
9. Sudre P et al. Treatment of chloroquine resistant malaria in African children: a cost-effectiveness analysis. International journal of epidemiology, 1992, 21: 146-153.
10. Premji Z et al. Community based studies on childhood mortality in a malaria holoendemic area on the Tanzanian coast. Acta tropica, 1997, 63: 101-109.
11. Ronn AM et al. High level of resistance of Plasmodium falciparum to sulfadoxine-pyrimethamine in children in Tanzania. Transactions of the Royal Society of Tropical Medicine and Hygiene, 1996, 90: 179-181.